<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Nkot, Jeanne Louise</dc:creator>
  <dc:creator>Ngono Bikobo, Dominique Serge</dc:creator>
  <dc:creator>Zintchem, Auguste Abouem A.</dc:creator>
  <dc:creator>Mbabi Nyemeck II, Norbert</dc:creator>
  <dc:creator>Moni Ndedi, Esther Del Florence</dc:creator>
  <dc:creator>Betote Diboué, Patrick Hervé</dc:creator>
  <dc:creator>Pegnyemb, Dieudonné Emmanuel</dc:creator>
  <dc:creator>Bochet, Christian G.</dc:creator>
  <dc:creator>Koert, Ulrich</dc:creator>
  <dc:date>2018-01-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Context: The roots of Lophira lanceolata Van Tiegh. Ex Keay (Ochnaceae) have  numerous medicinal values in the Central African region. Even though the MeOH  extract of the roots has shown antimycobacterial activities, the constituents  responsible for this inhibitory activity remain unknown.Objective: Phytochemical  investigation of the MeOH root extract of L. lanceolata and determination of the  antimycobacterial activities of that extract and constituents against the growth of  Mycobacterium tuberculosis.Materials and methods: Column chromatography was  used to provide bioactive phytoconstituents. Those compounds were elucidated using  MS and NMR spectroscopic data. Antimycobacterial screening of the extract (4.882–  5000 µg/mL in DMSO during 24 h at 37 °C) and isolated compounds (0.244–250  µg/mL in DMSO during 24 h at 37 °C) was performed by microplate alamar blue assay  (MABA) against two mycobacterial strains.Results: The investigation of L. lanceolata  MeOH roots extract provided of mixture of unseparated biflavonoids with a newly  described one, dihydrolophirone A (1a) associated to lophirone A (1b). The bioactive  compounds that effectively inhibited the growth of M. tuberculosis AC45 were found to  be compounds 1 and 2. They exhibited MIC values of 31.25 and 15.75 µg/mL,  respectively, and their MIC was found to be 62.5 µg/mL against resistant strain  AC83.Discussion and conclusions: It is clearly evident from the results obtained that  the mycobacterial activity of L. lanceolata could be related mainly to its steroid and  flavonoid contents. Therefore, this study suggests the potential of the above-  mentioned classes of compounds as promising candidate agents for developing new  anti-tuberculosis drugs.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307095</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307095/files/boc_aer.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307095/files/boc_aer_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1080/13880209.2018.1476559</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Pharmaceutical Biology. - 2018, vol. 56, no. 1, p. 318-324</dc:source>
  <dc:subject>info:eu-repo/classification/udc/54</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Antitubercular evaluation of root extract and isolated phytochemicals from Lophira lanceolata against two resistant strains of Mycobacterium tuberculosis</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
